Neuroscientific Biopharmaceuticals Ltd (NSB)

Currency in AUD
0.195
+0.005(+2.63%)
Closed·
NSB Scorecard
Full Analysis
Stock has taken a big hit over the last week
NSB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1900.195
52 wk Range
0.0330.260
Key Statistics
Bid/Ask
0.20 / 0.195
Prev. Close
0.19
Open
0.19
Day's Range
0.19-0.195
52 wk Range
0.033-0.26
Volume
95.55K
Average Volume (3m)
567.31K
1-Year Change
387.18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NSB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Neuroscientific Biopharmaceuticals Ltd Company Profile

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Perth, Australia.

Compare NSB to Peers and Sector

Metrics to compare
NSB
Peers
Sector
Relationship
P/E Ratio
53.2x−2.7x−0.5x
PEG Ratio
1.02−0.030.00
Price/Book
12.7x2.4x2.6x
Price / LTM Sales
28.6x8.6x3.3x
Upside (Analyst Target)
-294.3%43.4%
Fair Value Upside
Unlock2.5%7.1%Unlock

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NSB Income Statement

People Also Watch

23.63
CDA
+0.98%
0.205
ATX
+10.81%
0.770
MTM
+4.05%

FAQ

What Stock Exchange Does Neuroscientific Biopharma Trade On?

Neuroscientific Biopharma is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Neuroscientific Biopharma?

The stock symbol for Neuroscientific Biopharma is "NSB."

What Is the Neuroscientific Biopharma Market Cap?

As of today, Neuroscientific Biopharma market cap is 64.85M.

What Is Neuroscientific Biopharma's Earnings Per Share (TTM)?

The Neuroscientific Biopharma EPS (TTM) is 0.01.

From a Technical Analysis Perspective, Is NSB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Neuroscientific Biopharma Stock Split?

Neuroscientific Biopharma has split 0 times.

How Many Employees Does Neuroscientific Biopharma Have?

Neuroscientific Biopharma has 0 employees.

What is the current trading status of Neuroscientific Biopharma (NSB)?

As of 08 Aug 2025, Neuroscientific Biopharma (NSB) is trading at a price of 0.20, with a previous close of 0.19. The stock has fluctuated within a day range of 0.19 to 0.20, while its 52-week range spans from 0.03 to 0.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.